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【Abstract】Objective:    Hypokalemia is a frequent
complication observed after traumatic brain injury (TBI).
We evaluated the effect of spironolactone on preventing
hypokalemia following moderate to severe TBI.
Methods:    Patients with moderate to severe TBI, whose
Glasgow Coma Scale (GCS) scores of 9-12 and <9,
respectively, were equally randomized into intervention and
control groups, matching with severity of trauma and
baseline serum level of potassium. For the intervention
group, we administrated spironolactone (1 mg/kg per day)
on the second day of admission or the first day of gavage
tolerance and continued it for seven days. No additional
intervention was done for controls. Hypokalemia (mild: 3-3.5
mg/L, moderate: 2.5-3 mg/L, and severe: <2.5 mg/L serum
K+) and other electrolyte abnormalities were compared be-
tween the two groups at the end of the intervention.
Results:    Sixty-eight patients (58 males and 10 females)
were included with mean age=(33.1±11.8) years, and GCS=7.6
±2.8. The two groups were similar in baseline characteristics.
Patients who received spironolactone were significantly
less likely to experience mild, moderate, or severe hypokale-
mia (8.8%, 2.9%, and 0) compared with controls (29.4%, 11.7%,
and 2.9%, respectively, P<0.05). No significant difference
was observed between the two groups in the occurrence of
other electrolyte abnormalities, hyperglycemia or oliguria.
Conclusion:    Spironolactone within the first week of
head injury could prevent the occurrence of late hypokale-
mia with no severe side effects.
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I n both industrialized and non-industrializedcountries, the incidences of traumatic brain injury(TBI) are high and have been estimated to be 50-
250 per 100 000 population per year. TBI is a leading
cause of death and disability among a predominantly
young population worldwide with four main causes:
traffic, work, and sports accidents and violence.1 The
most common cause of head injury in Iran and other
developing countries is the road-traffic accident (RTA),
which is increasing in recent years.2,3
Following traumatic injury, significant hypokalemia
is a common complication at admission, which is more
frequent in those with traumatic brain and spinal cord
injuries.4 According to a report from our center, sodium-
potassium imbalance requiring medical intervention is
observed in 67% of the patients within the first week
following severe head injury.5 Moreover, in a pilot study of
30 patients in our department, 65% (13/20) of the patients
with moderate to severe head injuries who were not hy-
pokalemic at admission experienced hypokalemia during
the first week of hospitalization. The underlying mecha-
nisms of posttraumatic hypokalemia are not completely
understood yet. However, the role of posttraumatic cat-
echolamine release and subsequent intracellular potas-
sium shift has been reported by some studies.6, 7
The major clinical effects of hypokalemia, highly de-
pendent on its degree and rapidity of onset, are in myo-
cardial tissue (cardiac arrhythmias). Other adverse ef-
fects are in skeletal muscle (eg. cramping, respiratory
muscle paralysis) and the gastrointestinal system (eg.
vomiting, paralytic ileus).8 According to reports, hy-
pokalemic patients are more likely to need a ventilator
and have longer ICU and hospital lengths of stay.4 Ce-
rebral injury in itself is associated with myocardial dam-
age and various cardiac arrhythmias.9 Thus, develop-
ment of electrolyte imbalance such as hypokalemia
may increase the risk and severity of these complica-
tions after TBI. Also, induced hypothermia which is used
Chinese Journal of Traumatology 2010; 13(6):336-340 . 337 .
in some medical centers as a therapeutic strategy in
TBI10 contributes to severe hypokalemia (and other elec-
trolytes depletion), probably by a combination of intra-
cellular shift and increased urinary excretion through
hypothermia-induced polyuria.11-13 This electrolyte deple-
tion is associated with adverse outcomes and increased
risk of mortality in patients admitted to ICU.14 More
importantly, in patients with profound hypokalemia, ag-
gressive potassium replacement may cause rebound and
uncontrolled hyperkalemia with poor outcomes.15
Therefore, prevention of hypokalemia following trauma has
an important role in the management of patients with TBI.
Despite several observational studies on the occur-
rence of posttraumatic hypokalemia,4, 6, 7, 16, 17 there is no
report on how to prevent it. Potassium-sparing diuret-
ics are an alternative to exogenous potassium
supplementation. Spironolactone, a potassium-sparing
diuretic, acts as a partial antagonist for aldosterone
receptors and may also reduce the intracellular forma-
tion of active metabolites of aldosterone. Its diuretic
effect is due to inhibition of aldosterone activation at
distal tubules of kidney, thereby decreasing potassium
and increasing sodium elimination in the urine.8 The
aim of the present study was to evaluate the effect of
spironolactone in preventing hypokalemia following
moderate to severe TBI.
METHODS
This randomized, controlled, clinical trial was con-
ducted from July to December 2008 in Kashani Univer-
sity Hospital, Isfahan, Iran. The study was performed on
consecutive patients at age≥ 18 years who were ad-
mitted to the trauma service of the hospital with moder-
ate to severe TBI, whose Glasgow Coma Scale (GCS)
was 9-12, or <9. After admission, blood samples were
obtained for serum level of Na+, K+, glucose, blood urea
nitrogen, and Cr. Patients with electrolyte abnormalities,
hyperglycemia, or renal failure at admission and those
with a history of liver disease, diabetes, or using anti-
hypertensive/potassium-sparing drugs were excluded
from the study. CT scan was taken for all patients and
the following kinds of damage were specified: epidural
hematoma (EDH), subdural hematoma (SDH),
contusion, intracerebral hemorrhage (ICH), and diffuse
axonal injury (DAI). Calculated sample size per group
was 34, considering α=0.05, study power =80%, ef-
fect size=0.3, and 10% drop outs. Ethics Committee
of Isfahan University of Medical Sciences approved the
study and informed consents were obtained from all
patients or their families.
Eligible patients for the study were equally random-
ized into two groups using a computer generated ran-
dom table list,18 matching with severity of trauma (GCS<9
or GCS=9-12) and serum level of potassium (K+ = 3.5-4.2
mg/L or 4.3-5 mg/L). Sixty-eight patients were random-
ized to spironolactone and control groups. There were
58 males and 10 females with the mean age of (33.1
±11.8) years and the average GCS of 7.69±2.8.For the
intervention group, we administrated spironolactone
(1mg/kg per day) from the second day of admission
and continued it for seven days. If not tolerated by the
patient, administration of spironolactone was started
on the first day of gavage tolerance. No additional inter-
vention was done for the control group. Serum Na+, K+,
and glucose were checked daily and international nor-
malized ratio (INR), partial thromboplastin time (PTT),
prothrombin time (PT), serum glutamic-oxaloacetic tran-
saminase (SGOT), serum glutamic-pyruvic transami-
nase (SGPT) and bilirubin (direct and total) were
checked on the 3rd and 6th days of admission. Those
who encountered hypokalemia and needed supplemen-
tal potassium as well as those who encountered
hyperkalemia, hyperglycemia, hyponatremia, or abnor-
mality in renal or liver function tests stopped taking
spironolactone. During the study period, supplemental
potassium was administrated (intravenously or via
gavage) for any patient, either in the intervention or con-
trol group, who had serum K+<3.5 mg/L. After the inter-
vention period, hypokalemia, hyperkalemia, oliguria,
hyponatremia, hypernatremia, and hyperglycemia were
compared between the two groups. Electrolyte abnor-
malities were defined as follows: hypokalemia:serum K+
<3.5 mg/L (mild: 3 to 3.5, moderate: 2.5 to 3, and severe:
<2.5); hyperkalemia:serum K+>5.5 mg/L; hyponatremia:
serum Na+=135 mg/L; and hypernatremia:serum Na+>
145 mg/L.19,20 Hyperglycemia was defined by serum
glucose>2 000 mg/L and oliguria by urine output <400
ml/day. Data were analyzed using SPSS software ver-
sion 16.0 with Independent sample t-test and χ2 test.
In all tests, P<0.05 was considered statistically
significant.
RESULTS
There was no significant difference between the two
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groups in baseline characteristics (Table 1).
Overall, hypokalemia occurred in 19 patients (29.6%)
from day 2 to day 7 after admission (median=5th day).
The occurrence of mild to severe hypokalemia in two
groups categorizing with trauma severity is present in Table
2. The patients who received spironolactone were signifi-
cantly less likely to encounter mild, moderate, or severe
hypokalemia (8.8%, 2.9%, and 0) compared with con-
trols (29.4%, 11.7%, and 2.9%, P<0.05). Although the
difference was observed only for patients with severe TBI,
the correlation between the hypokalemia occurrence and
the severity of head injury was not statistically significant.
Totally 33% (14/42) of hypokalemia occurred in severe
TBI and 19.2% (5/26) in moderate TBI (P=0.163). In bivari-
ate analysis, only female gender was significantly asso-
ciated with the occurrence of hypokalemia (r=0.574, P
<0.001). Compared with male patients, females had
slightly lower GCS scores (6.2±3.0 vs 7.9±2.7, P=0.069)
which showed more severe head injury and were more
likely to suffer from EDH and SDH (P=0.047) and result-
ant need of surgical intervention (P=0.014). However, se-
verity of trauma or type of brain injury in CT scan was not
associated with occurrence of hypokalemia (Table 3) and
in univariate analysis controlling for GCS, gender was still
a significant predictor of hypokalemia occurrence (P<
0.001).
No significant difference was found between wo
groups in occurrence of other electrolyte abnormalities,
hyperglycemia, oliguria, or the average dose of adminis-
tered supplemental potassium (Table 4).
Data are shown as mean±SD or number (percentage). *Fisher’s exact test; **Independent sample t-test.
0.152*               0.50**            0.468**                                0.610*                                      0.500*
Table 1. Baseline characteristics of patients
       31/3              32.2±11.9        7.9±2.7    4 (11.7)    6 (17.6)         10 (29.4)         14 (41.2)   18 (52.9)
         27/7              34.1±11.7      7.44±2.8     2 (5.9)   10 (29.4)         10 (29.4)         12 (35.3)   19 (55.9)
Spironolactone
Control
P
Male/female       Age (years)       GCSGroups  CT findings
EDH           SDH       Contusion or ICH       DAI
Craniotomy
Table 3. Comparison of patients with and without hypokalemia
      10/9                        35.0±12.1             6.8±3.1        2 (5.8)         6 (17.6)           5 (14.7)           6 (17.6)
      48/1                         32.4±11.7             8.0±2.6        4 (11.7)      10 (29.4)         15 (44.1)         20 (58.8)
Data are shown as mean±SD or number (percentage). *Independent sample t-test; **Fisher’s exact test; ***Chi-square test.
  Male/female             Age (years)             GCSGroups                        CT findings
  EDH             SDH         Contusion or ICH       DAI
Hypokalemia
Non-hypokalemia
P <0.001**                      0.419*                0.147*                                       0.752***
Table 4. Comparison of electrolyte abnormalities between the spironolactone and control groups (n, %)
Spironolactone
Control
P
Groups                   Hyponatremia        Hypernatremia       Hyperglycemia       Oliguria           Supplemental potassium (mg)
    3 (8.8)                   6 (17.6)                   2 (5.9)                  0                             120.0±56.5
    4 (11.7)               10 (29.4)                   1 (2.9)                  2 (5.9)                     205.3±138.2
0.500*                   0.196*                    0.500*                  0.246*                         0.251**
Data are shown as mean±SD or number (percentage). *Fisher’s exact test;**Independent sample t-test.
Table 2. Comparison of hypokalemia between the spironolactone and control groups (n, %)
                                                Total                                                      Severe trauma                                   Moderate trauma
Mild
Moderate
Severe
Total
Spironolactone       Control P* Spironolactone       Control P* Spironolactone       Control P*
3 (8.8)
1 (2.9)
0
4 (11.8)
10 (29.4)
  4 (11.7)
  1 (2.9)
15 (44.1)
0.029
0.003
1 (4.7)
1 (4.7)
0
2 (9.5)
  8 (38.0)
  3 (14.2)
  1 (4.7)
12 (57.1)
0.012
0.001
2 (15.3)
0
0
2 (15.4)
2 (15.3)
1 (7.6)
0
3 (23.1)
0.592
0.500
*Fisher’s exact test
Hypokalemia
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DISCUSSION
Hypokalemia is reported in up to 68% of adults with
traumatic injuries at admission7 and is more frequent in
patients with TBI4. It may also occur during hospitaliza-
tion in a considerable amount of patients with normal
potassium at admission (44.1% in our control group).
The exact mechanisms of posttraumatic hypokalemia
are still unclear, but the role of catecholamine induced
intracellular potassium shift is widely accepted.6 Some
investigators believe that posttraumatic hypokalemia is
a transient and self-limited adaptive response to injury
that resolves within 24 hours to 36 hours after trauma
without need for treatment. A study by Beal et al4 in
2002 on 546 patients with traumatic injuries showed
that although hypokalemia at admission increases the
morbidity, it does not significantly increase the mortal-
ity (6.5% vs 5.5%). They also found no significant dif-
ference in the mortality comparing the severe, moderate,
and mild hypokalemia groups, although there was a
descending trend (12.0% vs 7.7% vs 3.4%). However,
other studies have showed that hypokalemia is associ-
ated with higher morbidity as well as mortality in adults
and children with head injury and other traumatic
injuries.21 The relationship between severity of hypokale-
mia and mortality was found in abdominal trauma and
supplemental potassium reduced the mortality rate in
these patients.22 Treatment of traumatic patients with
profound hypokalemia is difficult and there is a risk for
rebound severe hyperkalemia with poor outcomes.15
Moreover, as the results of the present and our pilot
study showed, late hypokalemia may occur within the
first week after trauma in 44% to 65% of patients with
normal serum potassium at admission. Therefore, we
believe that preventing hypokalemia is valuable for TBI
patients.
To the best of our knowledge, there is no report on
how to prevent posttraumatic hypokalemia. The results
of the present study showed that spironolactone (1 mg/kg
per day) can decrease the occurrence of hypokalemia
and its severity in adults with moderate to severe TBI
within the first week after trauma. Fortunately, admin-
istration of spironolactone is not associated with
hyponatremia, hyperglycemia, or other severe side
effects, which demonstrates it as a safe medication for
prevention of hypokalemia in TBI patients. However, its
benefit for other complications such as hypernatremia
or oliguria is not significant.
In the study by Vanek et al7, factors associated with
posttraumatic hypokalemia in adults included age, sys-
tolic blood pressure at admission, cardiac injury and
serum epinephrine level. Gender, mechanism of injury,
the number of organ systems injured, blood glucose
levels, serum alcohol level, arterial pH and trauma score
did not significantly correlate with hypokalemia at
admission. In contrast, we found that female gender is
a risk factor for occurrence of hypokalemia. Females
had more severe head injury and types of brain injury
were different. However, we did not find relationship be-
tween severity or type of head injury and hypokalemia.
Pomeranz et al17 also found no relationship between
GCS score and hypokalemia. They also showed that
age, sex and serum glucose level are not related to
posttraumatic hypokalemia. But, Lazar et al23 found di-
rect relationship between GCS score and hypokalemia
in children with mild head injury. These differences may
be attributed to different patient populations consider-
ing that we did not include patients who were hypokale-
mic at admission. The finding in our study that spirono-
lactone was more effective in preventing hypokalemia
in patients with severe trauma than in other patients
showed that this preventive strategy may be  helpful
especially for critically ill patients and routine adminis-
tration of spironolactone may not be meaningful.
However, this issue needs further large studies.
Unfortunately, we did not check for hypomagnesemia
in our patients. Hypomagnesemia which is seen in head
injured patients at admission and during induced
hypothermia14, 24 can contribute to the development of
hypokalemia because it reduces the intracellular po-
tassium level and promotes renal potassium wasting.
When concomitant hypokalemia and hypomagnesemia
occur, the magnesium deficiency should be corrected
first, otherwise full repletion of the potassium deficit is
difficult.8 According to Polderman et al’s14 study on TBI
patients treated with hypothermia, hypomagnesemia
was associated with hypokalemia in most of patients
and hypokalemia developed in many patients despite
substantial amounts of intravenous electrolyte
supplementation. Considering urinary loss of electro-
lytes seen in TBI patients treated with induced
hypothermia, spironolactone may prevent hypokalemia
in these patients, which deserves further trials.
In conclusion, the results of the present study
showed that spironolactone in the first week of head
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injury could prevent the occurrence of hypokalemia with
no severe side effects. However, further trials with larger
sample size are needed to confirm these results.
Acknowledgments
This study was supported by Isfahan University of Medi-
cal Sciences as a thesis for Neurosurgery Residency. We
are thankful to Ali Gholamrezaei (MD, Isfahan University of
Medical Sciences) who helped us prepare this report.
REFERENCES
1. Leon-Carrion J, Dominguez-Morales MR, Martin JM, et
al. Epidemiology of traumatic brain injury and subarachnoid
hemorrhage. Pituitary 2005;8:197-202.
2. Karbakhsh M, Zandi NS, Rouzrokh M, et al. Injury epide-
miology in Kermanshah: the National Trauma Project in Islamic
Republic of Iran. East Mediterr Health J 2009;15(1):57-64.
3. Montazeri A. Road-traffic-related mortality in Iran: a de-
scriptive study. Public Health 2004;118(2):110-113.
4. Beal AL, Scheltema KE, Beilman GJ, et al. Hypokalemia
following trauma. Shock 2002;18(2):107-110.
5. Aminmansour B, Moein H. The prognostic value of factors
involved in secondary damage in the early phase of severe head
injury. J Res Med Sci 2003;8:11-16.
6. Beal AL, Deuser WE, Beilman GJ. A role for epinephrine in
post-traumatic hypokalemia. Shock 2007;27(4):358-363.
7. Vanek VW, Seballos RM, Chong D, et al. Serum potassium
concentrations in trauma patients. South Med J 1994;87(1):41-46.
8. Brophy DF, Gehr TWB. Disorders of potassium and mag-
nesium homeostasis. In: DiPiro JT, Talbert RL, Yee GC, et al, eds.
Pharmacotherapy. A pathophysiologic approach. 7th ed. New
York: McGraw-Hil Medical, 2008:877-888.
9. Keller C, Williams A. Cardiac dysrhythmias associated with
central nervous system dysfunction. J Neurosci Nurs 1993;25(6):
349-355.
10. Peterson K, Carson S, Carney N. Hypothermia treatment
for traumatic brain injury: a systematic review and meta-analysis.
J Neurotrauma 2008;25(1):62-71.
11. Jiang JY. Clinical study of mild hypothermia treatment for
severe traumatic brain injury. J Neurotrauma 2009;26(3):399-406.
12. Tokutomi T, Miyagi T, Morimoto K, et al. Effect of hy-
pothermia on serum electrolyte, inflammation, coagulation, and
nutritional parameters in patients with severe traumatic brain
injury. Neurocrit Care 2004;1(2):171-182.
13. Tokutomi T, Miyagi T, Takeuchi Y, et al. Effect of 35
degrees C hypothermia on intracranial pressure and clinical out-
come in patients with severe traumatic brain injury. J Trauma
2009;66(1):166-173.
14. Polderman KH, Bloemers FW, Peerdeman SM, et al. Hy-
pomagnesemia and hypophosphatemia at admission in patients
with severe head injury. Crit Care Med 2000;28(6):2022-2025.
15. Schaefer M, Link J, Hannemann L, et al. Excessive hy-
pokalemia and hyperkalemia following head injury. Intensive Care
Med 1995;21(3):235-237.
16. Paret G, Tirosh R, Lotan D, et al. Early prediction of
neurological outcome after falls in children: metabolic and clinical
markers. J Accid Emerg Med 1999;16(3):186-188.
17. Pomeranz S, Constantini S, Rappaport ZH. Hypokalaemia
in severe head trauma. Acta Neurochir (Wien) 1989;97(1-2):62-
66.
18. Saghaei M. Random allocation software for parallel group
randomized trials. BMC Med Res Methodol 2004;4:26.
19. Brophy DF, Gehr TWB. Disorders of potassium and
magnesium homeostasis. In: DiPiro JT, Talbert RL, Yee GC, et al,
eds. Pharmacotherapy. A pathophysiologic approach. New York:
McGraw-Hill Medical, 2008:877-888.
20. Coyle JD, Joy MS. Disorders of sodium and water
homeostasis. In: DiPiro JT, Talbert RL, Yee GC, et al, eds.
Pharmacotherapy. A pathophysiologic approach. 7th ed. New
York: McGraw-Hill Medical, 2008: 845-860.
21. Paret G, Tirosh R, Lotan D, et al. Early prediction of
neurological outcome after falls in children: metabolic and clinical
markers. J Accid Emerg Med 1999;16(3):186-188.
22. Smith JS Jr. Hypokalemia in resuscitation from multiple
trauma. Surg Gynecol Obstet 1978;147(1):18-20.
23. Lazar L, Erez I, Gutermacher M, et al. Brain concussion
produces transient hypokalemia in children. J Pediatr Surg 1997;
32(1):88-90.
24. Polderman KH, Peerdeman SM, Girbes AR. Hypophos-
phatemia and hypomagnesemia induced by cooling in patients
with severe head injury. J Neurosurg 2001;94(5):697-705.
(Received March 18, 2010)
Edited by LIU Jun-lan
